|
Soler-Espejo E, Ramos-Bratos MP, Gonzalez-Lozano E, Lip GYH, Marin F, Rivera-Caravaca JM, Roldan V. Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation. Eur J Prev Cardiol. 2025 May 14:zwaf287. doi: 10.1093/eurjpc/zwaf287. Online ahead of print. PubMed PMID: 40366897.
AÑO: 2025; IF: 7.5
|
40366897
|
Soler-Espejo E., Marín F., López-Gálvez R., Ramos-Bratos M.P., Sánchez-Villalobos M., Esteve-Pastor M.A., Lip G.Y.H., Rivera-Caravaca J.M., Roldán V. The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study. Clinical Cardiology. February 2025. 48. 10.1002/clc.70102
AÑO: 2025; IF: 2.3
|
|
Soler-Espejo E., Roldán V., Marín F. Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism. Thrombosis and Haemostasis. 2025. 10.1055/a-2520-8725
AÑO: 2025; IF: 4.3
|
|
Soler-Espejo E, Marin F, Roldan V, Rivera-Caravaca JM. What is the impact of dynamic score reassessment for stroke and bleeding risk outcome prediction in atrial fibrillation patients? Expert Rev Cardiovasc Ther. 2025 Apr;23(4):107-112. doi: 10.1080/14779072.2025.2489725. Epub 2025 Apr 10. PubMed PMID: 40202395.
AÑO: 2025; IF: 2.1
|
|
Rivera-Caravaca JM, Menichelli D, Pastori D, Soler-Espejo E, Esteve-Pastor MA, Vivas D, Roldan I, Anguita M, Luis Ferreiro J, Roldan V, Marin F; Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology. Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries. Med Clin (Barc). 2025 Jun 3;165(3):107031. doi: 10.1016/j.medcli.2025.107031. Online ahead of print. English, Spanish. PubMed PMID: 40466270.
AÑO: 2025; IF: 2.1
|